DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Plaque Psoriasis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Plaque Psoriasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Plaque Psoriasis development. The report provides ...
January 2020
60 pages
Pleural Effusion - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Pleural Effusion - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pleural Effusion development. The report provides ...
January 2020
60 pages
Polycystic Kidney Disease - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Polycystic Kidney Disease The report also ...
January 2020
60 pages
Polycythemia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Polycythemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Polycythemia development. The report provides detailed ...
January 2020
60 pages
Polymyositis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Polymyositis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Polymyositis development. The report provides detailed ...
January 2020
90 pages
Porphyria - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Porphyria - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Porphyria development. The report provides detailed ...
January 2020
60 pages
Postherpetic Neuralgia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Postherpetic Neuralgia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Postherpetic Neuralgia development. The report provides ...
January 2020
60 pages
Postmenopausal Vaginal Atrophy - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Postmenopausal Vaginal Atrophy The report also ...
January 2020
60 pages
Premature Ejaculation - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Premature Ejaculation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Premature Ejaculation development. The report provides ...
January 2020
60 pages
Premature Labor (Tocolysis) - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Premature Labor (Tocolysis) The report also ...
January 2020
60 pages
Pressure Ulcers - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Pressure Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pressure Ulcers development. The report provides ...
January 2020
120 pages
Primary Immune Deficiency (PID) - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Primary Immune Deficiency (PID) The report also ...
January 2020
60 pages
Progressive Multifocal Leukoencephalopathy - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Progressive Multifocal Leukoencephalopathy The report also ...
January 2020
60 pages
Pyelonephritis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Pyelonephritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pyelonephritis development. The report provides detailed ...
January 2020
90 pages
Radiation Toxicity - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Radiation Toxicity - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Radiation Toxicity development. The report provides ...
January 2020
60 pages
Raynauds Disease - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Raynauds Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Raynauds Disease development. The report provides ...
January 2020
60 pages
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Relapsed Chronic Lymphocytic Leukemia (CLL) The report also ...
January 2020
60 pages
Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Relapsing Multiple Sclerosis (RMS) The report also ...
January 2020
60 pages
Renal Anemia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Renal Anemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Renal Anemia development. The report provides ...
January 2020
60 pages
Resistant Hypertension - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Resistant Hypertension - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Resistant Hypertension development. The report provides ...
January 2020
60 pages
Restless Legs Syndrome - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Restless Legs Syndrome The report also ...
January 2020
60 pages
Retinopathy Of Prematurity - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Retinopathy Of Prematurity The report also ...
January 2020
60 pages
Rhino-Conjunctivitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Rhino-Conjunctivitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rhino-Conjunctivitis development. The report provides detailed ...
January 2020
60 pages
